A
ACXP
Acurx Pharmaceuticals Inc
1.970
+0.040+2.07%After Hours: 2.040 +0.070 +3.55%19:41 05/22 EDT
OPEN/PREV CLOSE2.060/1.930
TODAY RANGE1.970-2.220
VOL250.47K
MARKET CAP8.47M
52 WEEK RANGE1.326-21.00
AVG VOL (3M)3.10M
% TURNOVER5.83%
TURNOVER--
P/E (TTM)-0.4418
% RANGE12.44%
EPS(TTM)-4.4592
P/E(FORWARD)-1.3311
P/B0.9520
BVPS2.069
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.21M
SHARES OUTSTANDING4.30M
NEXT EARNINGS08/10-08/14
FREE FLOAT4.17M
LOT SIZE1
EX-DATE08/05/2025
News
Press Releases
Financial Reports
Profile
TipRanks·05/13 00:14
Acurx Pharmaceuticals Charts Risky but Promising CDI Path
Seeking Alpha·05/12 15:01
Acurx outlines August first patient for 20-patient rCDI pilot as it weighs FDA one-trial path
TipRanks·05/12 13:00
Acurx reports Q1 EPS (62c) vs. ($2.15) last year
Seeking Alpha·05/12 12:30
Acurx Pharmaceuticals GAAP EPS of -$0.62
Reuters·05/12 11:39
Acurx Pharmaceuticals Q1 net loss narrows as expenses fall
Dow Jones·05/12 11:01
Press Release: Acurx Pharmaceuticals, Inc. -2-
Dow Jones·05/12 11:01
*Acurx Pharmaceuticals 1Q Loss $1.68M >ACXP
Dow Jones·05/12 11:01
*Acurx Pharmaceuticals 1Q Loss/Shr 62c >ACXP
TipRanks·05/04 20:30
Acurx files to sell 1.65M shares of common stock for holders
TipRanks·05/04 20:29
Acurx files to sell 1.3M shares of common stock for holders